Middle East & Africa Peptide Microarray Market Size & Outlook
Related Markets
MEA peptide microarray market highlights
- The MEA peptide microarray market generated a revenue of USD 40.8 million in 2023.
- The market is expected to grow at a CAGR of 5.2% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating type in 2023.
- Services is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 40.8 million |
| Market revenue in 2030 | USD 58.3 million |
| Growth rate | 5.2% (CAGR from 2024 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents, Services |
| Key market players worldwide | PEPperPRINT, RayBiotech, Creative-Biolabs, Aurora Innovation Inc Class A, Spectrum Solutions, Bio-Rad Laboratories Inc, BioNTech SE ADR, Merck KGaA, Innopsys |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.9% of the global peptide microarray market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 166.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Microarray Market Scope
Peptide Microarray Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Innopsys | View profile | - | Carbonne, Midi-Pyrenees, France, Europe | https://www.innopsys.com |
| Spectrum Solutions | View profile | 51-100 | Utah, Tennessee, United States, North America | http://www.spectrum-solutions.us |
| PEPperPRINT | View profile | 11-50 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.pepperprint.com |
| Creative-Biolabs | View profile | 51-100 | Shirley, New York, United States, North America | https://www.creative-biolabs.com |
| RayBiotech | View profile | 101-250 | Norcross, Georgia, United States, North America | http://www.raybiotech.com/ |
| BioNTech SE ADR | View profile | 6133 | An der Goldgrube 12, Mainz, RP, Germany, D-55131 | https://www.biontech.de |
| Aurora Innovation Inc Class A | View profile | 1800 | 1654 Smallman Street, Pittsburgh, PA, United States, 15222 | https://www.aurora.tech |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Middle East & Africa peptide microarray market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide microarray market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 56.37% in 2023. Horizon Databook has segmented the Middle East & Africa peptide microarray market based on instruments, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa peptide microarray market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa peptide microarray market databook
-
Our clientele includes a mix of peptide microarray market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa peptide microarray market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa peptide microarray market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA peptide microarray market report size, by country, 2018-2030 (US$M)
Middle East & Africa Peptide Microarray Market Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
